Cargando…

Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors

PURPOSE: To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). METHODS: Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to J...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bin, Chen, Yan, Chen, Lifeng, Chen, Huan, Zheng, Jingwei, Chen, Feng, Song, Zongming, Fu, Lin, Hu, Xuting, Pan, Jiandong, Lian, Hengli, Shen, Lijun, Li, Qiuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334322/
https://www.ncbi.nlm.nih.gov/pubmed/30719338
http://dx.doi.org/10.1155/2019/7464123
_version_ 1783387687380582400
author Zheng, Bin
Chen, Yan
Chen, Lifeng
Chen, Huan
Zheng, Jingwei
Chen, Feng
Song, Zongming
Fu, Lin
Hu, Xuting
Pan, Jiandong
Lian, Hengli
Shen, Lijun
Li, Qiuming
author_facet Zheng, Bin
Chen, Yan
Chen, Lifeng
Chen, Huan
Zheng, Jingwei
Chen, Feng
Song, Zongming
Fu, Lin
Hu, Xuting
Pan, Jiandong
Lian, Hengli
Shen, Lijun
Li, Qiuming
author_sort Zheng, Bin
collection PubMed
description PURPOSE: To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). METHODS: Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to July 2017 were included. The main outcomes included treatment type, tumor activity, and best-corrected visual acuity (BCVA). RESULTS: Altogether, 16 patients with 17 eyes were enrolled with follow-up of no less than 6 months. Eight eyes were in the resection treatment group (Group R) and 9 eyes were in the conservative treatment group (Group C). Female (69%) were more common. The mean age was 50 (49.72 ± 12.92) years. Fifteen patients got unilateral onset and only one patient suffered bilaterally. The common symptoms were decreased visual acuity, floaters, and visual distortion. The preoperative BCVA ranged from hand movement to 20/20, with an average of 0.82 ± 0.75 LogMAR. Patients were all not high myopia, with a mean axial length of 23.27 ± 0.27 mm (21.61 mm to 24.67 mm). Of the retinal diseases, the epiretinal membrane was the most common, followed by vitreous hemorrhage, uveitis, subretinal fluid, and so on. Compared with the baseline BCVA, it improved more at postoperative 6 months and the last visit in Group R than in Group C (P=0.006 and P=0.033). The BCVA-improved 0.2 LogMAR or above in 6 months was 2 eyes in Group C and 7 eyes in Group R. All tumors in Group R were completely resected, whereas three in Group C (33.3%) had definite activity (P=0.008). In all samples, tumors were located on the inner side of the retina and had small vessel wall thickening and hyaline degeneration. The degree of astrocyte proliferation varies widely among different tumors. CONCLUSIONS: RVPT was more likely to occur in nonhigh myopia patients. Epiretinal membrane and vitreous hemorrhage were the main causes for vitreous surgery in RVPT patients. Compared with conservative treatment, surgical resection of the tumor is more beneficial to patients on visual acuity recovery and preventing tumor relapse. It is a safe and effective way to treat RVPT.
format Online
Article
Text
id pubmed-6334322
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63343222019-02-04 Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors Zheng, Bin Chen, Yan Chen, Lifeng Chen, Huan Zheng, Jingwei Chen, Feng Song, Zongming Fu, Lin Hu, Xuting Pan, Jiandong Lian, Hengli Shen, Lijun Li, Qiuming J Ophthalmol Research Article PURPOSE: To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). METHODS: Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to July 2017 were included. The main outcomes included treatment type, tumor activity, and best-corrected visual acuity (BCVA). RESULTS: Altogether, 16 patients with 17 eyes were enrolled with follow-up of no less than 6 months. Eight eyes were in the resection treatment group (Group R) and 9 eyes were in the conservative treatment group (Group C). Female (69%) were more common. The mean age was 50 (49.72 ± 12.92) years. Fifteen patients got unilateral onset and only one patient suffered bilaterally. The common symptoms were decreased visual acuity, floaters, and visual distortion. The preoperative BCVA ranged from hand movement to 20/20, with an average of 0.82 ± 0.75 LogMAR. Patients were all not high myopia, with a mean axial length of 23.27 ± 0.27 mm (21.61 mm to 24.67 mm). Of the retinal diseases, the epiretinal membrane was the most common, followed by vitreous hemorrhage, uveitis, subretinal fluid, and so on. Compared with the baseline BCVA, it improved more at postoperative 6 months and the last visit in Group R than in Group C (P=0.006 and P=0.033). The BCVA-improved 0.2 LogMAR or above in 6 months was 2 eyes in Group C and 7 eyes in Group R. All tumors in Group R were completely resected, whereas three in Group C (33.3%) had definite activity (P=0.008). In all samples, tumors were located on the inner side of the retina and had small vessel wall thickening and hyaline degeneration. The degree of astrocyte proliferation varies widely among different tumors. CONCLUSIONS: RVPT was more likely to occur in nonhigh myopia patients. Epiretinal membrane and vitreous hemorrhage were the main causes for vitreous surgery in RVPT patients. Compared with conservative treatment, surgical resection of the tumor is more beneficial to patients on visual acuity recovery and preventing tumor relapse. It is a safe and effective way to treat RVPT. Hindawi 2019-01-02 /pmc/articles/PMC6334322/ /pubmed/30719338 http://dx.doi.org/10.1155/2019/7464123 Text en Copyright © 2019 Bin Zheng et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zheng, Bin
Chen, Yan
Chen, Lifeng
Chen, Huan
Zheng, Jingwei
Chen, Feng
Song, Zongming
Fu, Lin
Hu, Xuting
Pan, Jiandong
Lian, Hengli
Shen, Lijun
Li, Qiuming
Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_full Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_fullStr Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_full_unstemmed Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_short Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
title_sort comparative study on the efficacy and safety of tumor resection in vitrectomy for retinal vasoproliferative tumors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334322/
https://www.ncbi.nlm.nih.gov/pubmed/30719338
http://dx.doi.org/10.1155/2019/7464123
work_keys_str_mv AT zhengbin comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT chenyan comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT chenlifeng comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT chenhuan comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT zhengjingwei comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT chenfeng comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT songzongming comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT fulin comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT huxuting comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT panjiandong comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT lianhengli comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT shenlijun comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors
AT liqiuming comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors